Mirvaso Brimonidine Gel 0.33% for Rosacea Redness Relief

Description

Mirvaso is a prescription-only topical gel for adults with rosacea who want visible, temporary reduction of persistent facial redness (erythema). It contains brimonidine, an alpha agonist that narrows small facial blood vessels to reduce excess blood flow and redness. Mirvaso is applied once daily as a thin layer across the face, with a maximum daily dose of 1 gram (about 5 pea-sized amounts).

At a glance

What Mirvaso treats (and what it does not)

• Treats the redness (erythema) of rosacea by narrowing small blood vessels in the facial skin.
• Does not treat rosacea bumps/spots directly. If you also have inflammatory lesions, a prescriber may advise another rosacea treatment alongside Mirvaso.
• Mirvaso can be used with other rosacea skin medicines and cosmetics, but only after Mirvaso has dried (do not apply other products immediately before Mirvaso).

How Mirvaso works

Rosacea redness is linked to increased blood flow in superficial facial blood vessels. Brimonidine is an alpha-2 adrenergic agonist. When applied to the skin, it causes these vessels to constrict, reducing blood flow and improving the appearance of facial redness.

How to use Mirvaso (dosage and application)

1. Clean the face gently and let the skin dry fully.
2. Start with a small amount during week 1 (less than the maximum dose).
3. Apply a very thin, even layer across the whole face: forehead, chin, nose, and both cheeks.
4. Use up to five pea-sized amounts in total (one for each area). Do not exceed 1 g in 24 hours.
5. Avoid eyes, eyelids, lips, mouth, and the inside of the nose. Rinse with plenty of water if contact occurs.
6. Wash hands immediately after applying.
7. If you use other skincare, cosmetics, or rosacea medicines, apply them only after Mirvaso has dried.

Mirvaso is applied once daily only. Do not apply more than once per day.

How quickly does Mirvaso work and how long does it last?

Many people notice reduced redness within about 30 minutes, although the onset can range from around 30 minutes to several hours. The effect gradually diminishes hours after application and may last up to 12 hours depending on individual response.

Important safety note: worsening redness (exacerbation or rebound)

Worsening of rosacea symptoms is very common with Mirvaso. In clinical studies, symptom exacerbation occurred in about 16% of patients. Some people experience redness or flushing returning worse than baseline, most often within the first 2 weeks.

• Start low and go slow: begin with less than the maximum dose for at least 1 week and increase gradually based on tolerability.
• Do not exceed the maximum daily dose (1 g total; about 5 pea-sized amounts).
• Stop Mirvaso and seek medical advice if you develop worsening redness, flushing, or burning.
• If restarting after a worsening episode, test on a small facial area on a day you can stay at home.

Who should NOT use Mirvaso (or needs advice first)

Do not use Mirvaso if:

• You are allergic to brimonidine or any ingredient in the gel.
• You are taking monoamine oxidase (MAO) inhibitors (e.g., selegiline, moclobemide).
• You are taking tricyclic or tetracyclic antidepressants that affect noradrenergic transmission (e.g., imipramine, maprotiline, mianserin, mirtazapine).
• The patient is a child under 2 years (serious systemic safety risk). Mirvaso should not be used under 18 years.

Speak to a prescriber before use if you have:

• Heart or circulation problems, low blood pressure (especially on standing), or reduced blood flow to hands/feet.
• Depression, reduced blood flow to the brain or heart, or Sjogren’s syndrome.
• Irritated facial skin, open wounds, or you recently had (or plan) laser procedures on facial skin.
• Kidney or liver problems (current or past).

Pregnancy and breastfeeding

Mirvaso is not recommended during pregnancy because effects on the unborn baby are unknown. Do not use Mirvaso during breastfeeding because it is unknown whether it passes into breast milk. Discuss alternatives if you are pregnant, planning pregnancy, or breastfeeding.

Medicine interactions to mention in your consultation

• MAO inhibitors and certain antidepressants (see contraindications above).
• Medicines for pain, sleep disorders, or anxiety; and some psychiatric medicines (e.g., chlorpromazine).
• Other alpha agonists (e.g., clonidine) or alpha blockers/antagonists (e.g., prazosin, isoprenaline).
• Cardiac glycosides (e.g., digoxin).
• Blood pressure medicines such as beta-blockers or calcium channel blockers (e.g., propranolol, amlodipine).

Possible side effects

Common side effects (up to 1 in 10):

• Flushing.
• Excessive whitening (pallor) where applied.
• Skin redness, burning feeling, or itching.

Uncommon side effects (up to 1 in 100):

• Acne, dry mouth, headache, dizziness, nasal congestion.
• Swelling of the eyelid, urticaria, feeling hot or cold hands/feet.

Rare side effects (up to 1 in 1,000):

• Low blood pressure (hypotension).
• Slow heart rate (bradycardia).

Stop using Mirvaso and seek medical advice if you develop severe irritation, rash, swelling of the face/mouth/tongue, breathing difficulty, or if redness/burning becomes worse during treatment.

Strength and pack sizes

Mirvaso is supplied in tubes containing 2 g, 10 g, or 30 g of gel, or a 30 g airless pump system. Not all pack sizes may be marketed. At the maximum recommended daily dose (1 g), a 30 g pack can last around 1 month.

Storage

• Store below 30C and do not freeze.
• No special storage conditions are required.
• Keep out of sight and reach of children.

Buy Mirvaso gel online in the UK

Mirvaso is a prescription-only medicine (POM) in the UK. Ordering online typically involves a short clinical questionnaire so a prescriber can confirm your symptoms are consistent with rosacea redness, check contraindications and interaction risks, and confirm safe use.

How to order from MedCare

1. Complete the online consultation (clinical questionnaire).
2. A prescriber reviews your answers for suitability and safety.
3. If approved, your prescription is issued and your order is dispensed.
4. Receive your medicine in discreet packaging with support available if you have questions.

Why choose MedCare Health Clinic and Pharmacy?

• Private prescriptions after a quick online consultation.
• Discreet UK delivery for prescription dermatology treatments.
• Clear dosing guidance and safety screening for interacting medicines.

FAQs

Is Mirvaso prescription-only in the UK?

Yes. Mirvaso is a prescription-only medicine (POM) and should be supplied after a clinician confirms it is suitable for you.

How do I apply Mirvaso correctly?

Apply once daily as a thin layer across the whole face: forehead, chin, nose, and both cheeks. Use up to five pea-sized amounts total (max 1 g).

How fast does Mirvaso work and how long does it last?

Redness reduction can begin within about 30 minutes (sometimes longer). The effect gradually diminishes hours after application and may last up to 12 hours.

Can Mirvaso make redness worse?

Yes. Some patients experience worsening redness, flushing, or burning (sometimes worse than baseline), most often within the first 2 weeks. Start with less than the maximum dose and increase gradually. Stop and seek advice if symptoms worsen.

Can I use Mirvaso with other rosacea treatments or makeup?

Yes. Mirvaso can be used with other rosacea skin medicines and cosmetics, but apply them only after Mirvaso has dried. Avoid applying other products immediately before Mirvaso.